Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69


Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China.

Zhu F, Hu Y, Li J, Ye Q, Young MM Jr, Liang JZ, Gruber WC, Giardina PC, Scott DA.

Pediatr Infect Dis J. 2019 Nov;38(11):1150-1158. doi: 10.1097/INF.0000000000002458.


Precision immunization: a new trend in human vaccination.

Jia S, Li J, Liu Y, Zhu F.

Hum Vaccin Immunother. 2019 Sep 23. doi: 10.1080/21645515.2019.1670123. [Epub ahead of print]


The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.

Ge Y, Chi Y, Min X, Zhao K, Wu B, Wu T, Zhu X, Shi Z, Zhu F, Cui L.

Virology. 2019 Oct;536:58-67. doi: 10.1016/j.virol.2019.08.004. Epub 2019 Aug 6.


Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12-23 months in China.

Hu J, Li H, Chu K, Liang Q, Li J, Luo L, Hu Y, Meng F, Zhu F.

Hum Vaccin Immunother. 2019 Jul 26:1-8. doi: 10.1080/21645515.2019.1627816. [Epub ahead of print]


Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China.

Ruan B, Yu Z, Yang S, Xu K, Ren J, Yao J, Wu N, Yu C, Deng M, Xie T, Chen P, Wang C, Li Y, Zhao Y, Sheng J, Hou Y, Wu Z, Jin S, Chen Y, Li M, Zhu F, Tang H, Hao Y, Pang X, Lu L, Yang W, Yuan Z, Xu A, Li Z, Ni M, Yan Y, Zhong Q, Zhou L, Li G, Meng Q, Hu J, Zhou H, Zhang G, Li D, Jiang W, Li Q, Wu P, Xing R, Gu J, Gao D, Li L.

BMC Infect Dis. 2019 Jul 12;19(1):617. doi: 10.1186/s12879-019-4150-9.


Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.

Hu Y, Guo M, Li C, Chu K, He W, Zhang J, Gu J, Li J, Zhao H, Wu X, Lin B, Lin Z, Yao X, Li Y, Wei F, Huang Y, Su Y, Zhu F, Huang S, Pan H, Wu T, Zhang J, Xia N.

Sci China Life Sci. 2019 Jun 21. doi: 10.1007/s11427-019-9547-7. [Epub ahead of print]


A Cluster of Bunyavirus-Associated Severe Fever With Thrombocytopenia Syndrome Cases in a Coastal Plain Area in China, 2015: Identification of a Previously Unidentified Endemic Region for Severe Fever With Thrombocytopenia Bunyavirus.

Hu J, Li Z, Cai J, Liu D, Zhang X, Jiang R, Guo X, Liu D, Zhang Y, Cui L, Shen J, Zhu F, Bao C.

Open Forum Infect Dis. 2019 May 13;6(6):ofz209. doi: 10.1093/ofid/ofz209. eCollection 2019 Jun.


Environmental Risk Factors and Geographic Distribution of Severe Fever with Thrombocytopenia Syndrome in Jiangsu Province, China.

Zhang D, Sun C, Yu H, Li J, Liu W, Li Z, Bao C, Liu D, Zhang N, Zhu F, Hu J.

Vector Borne Zoonotic Dis. 2019 Oct;19(10):758-766. doi: 10.1089/vbz.2018.2425. Epub 2019 Apr 17.


Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.

Hu Y, Wang J, Zeng G, Chu K, Jiang D, Zhu F, Ying Z, Chen L, Li C, Zhu F, Yin W.

J Infect Dis. 2019 Oct 8;220(10):1551-1557. doi: 10.1093/infdis/jiy736.


Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains.

Tang R, Chu K, Hu Y, Chen L, Zhang M, Liu S, Ma H, Wang J, Zhu F, Hu Y, Gao Q.

Hum Vaccin Immunother. 2019;15(5):1160-1166. doi: 10.1080/21645515.2019.1572410. Epub 2019 Mar 19.


Rapid detection of human mastadenovirus species B by recombinase polymerase amplification assay.

Wu T, Wu H, Zhao K, Hu C, Ge Y, Zhu X, Zhang X, Zhou M, Zhu F, Cui L.

BMC Microbiol. 2019 Jan 8;19(1):8. doi: 10.1186/s12866-018-1365-7.


A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5.

Mao Q, Hao X, Hu Y, Du R, Lang S, Bian L, Gao F, Yang C, Cui B, Zhu F, Shen L, Liang Z.

Emerg Microbes Infect. 2018 Nov 21;7(1):185. doi: 10.1038/s41426-018-0186-y.


Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.

Zhu L, Zhai X, Wang Q, Jiang J, Peng H, Song C, Ge Z, Qian J, Zhou M, Zhou Y, Xu J, Liu H, Hang D, Hu Z, Shen H, Zhu F.

J Viral Hepat. 2018 Dec;25(12):1588-1598. doi: 10.1111/jvh.12978. Epub 2018 Sep 11.


Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.

Zhu L, Jiang J, Zhai X, Baecker A, Peng H, Qian J, Zhou M, Song C, Zhou Y, Xu J, Liu H, Hang D, Hu Z, Shen H, Zhang ZF, Zhu F.

Liver Int. 2019 Jan;39(1):70-80. doi: 10.1111/liv.13933. Epub 2018 Aug 19.


One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study.

Hu J, Jiao L, Hu Y, Chu K, Li J, Zhu F, Li T, Wu Z, Wei D, Meng F, Wang B.

Hum Vaccin Immunother. 2018;14(11):2701-2705. doi: 10.1080/21645515.2018.1486154. Epub 2018 Jul 11.


Pyroptosis induced by enterovirus A71 infection in cultured human neuroblastoma cells.

Zhu X, Wu T, Chi Y, Ge Y, Wu B, Zhou M, Zhu F, Ji M, Cui L.

Virology. 2018 Aug;521:69-76. doi: 10.1016/j.virol.2018.05.025. Epub 2018 Jun 7.


A cross-sectional seroepidemiology study of EV-D68 in China.

Sun S, Gao F, Hu Y, Bian L, Wu X, Su Y, Du R, Fu Y, Zhu F, Mao Q, Liang Z.

Emerg Microbes Infect. 2018 Jun 6;7(1):99. doi: 10.1038/s41426-018-0103-4.


Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation.

Hu Y, Zeng G, Chu K, Zhang J, Han W, Zhang Y, Li J, Zhu F.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1517-1523. doi: 10.1080/21645515.2018.1442997. Epub 2018 Apr 11.


Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.

Wang Y, Li J, Wang Y, Gu W, Zhu F.

Hum Vaccin Immunother. 2018 Apr 3;14(4):1003-1012. doi: 10.1080/21645515.2017.1409316. Epub 2017 Dec 21. Review.

Supplemental Content

Loading ...
Support Center